Latest

The READOUT
The Readout

Prison time for a legend & a VC firm on the defensive

By Damian Garde

Pregnant woman
Morning Rounds

Vaccines in pregnant women & a sun sensor

By Megan Thielking

AI neuron illustration
First Opinion

Artificial intelligence in pharma, health care: at the crossroads of hype and reality

By Grant Stephen and Michael Jacobson

Hoarding Opioids
First Opinion

Overzealous use of the CDC’s opioid prescribing guideline is harming pain patients

By Kate M. Nicholson, Diane E. Hoffman, and Chad D. Kollas

Donald Trump & Xi Jinping
Politics

The Trump administration called this biotech VC firm a suspicious agent of China. It’s run by U.S. citizens

By Rebecca Robbins

Memorial Sloan Kettering
Hospitals

Top cancer center’s business deals created a web of conflicts, say ethics experts

By Casey Ross and Ike Swetlitz

Steve Burrill
Biotech

Legendary biotech VC Steven Burrill sentenced to 2.5 years for fraud

By Damian Garde

Pharmalot

Pharmalittle: Takeda shareholders approve Shire deal; HPV vaccine program in Quebec divides experts

By Ed Silverman

Overprescribing Painkillers
Pharmalot

Investor activists win again and persuade Endo to catalog opioid risks

By Ed Silverman

CVS/Aetna
Pharmalot

CVS boasts that a new pricing model will lower drug costs for health plans. Will it?

By Ed Silverman

The READOUT
The Readout

Moderna’s big day out & Vertex’s odds of making NICE

By Damian Garde

Hang Up Lab Coat
Morning Rounds

Birth after uterus transplant & medical school diversity

By Megan Thielking

Facebook cracked screen
First Opinion

Ferreting out prescription drug scams on social media

By Rick Battelle

Pregnancy window
First Opinion

When women are denied an abortion, their children fare worse than peers

By Diana Greene Foster

In the Lab

A shot-in-the-dark email leads to a century-old family treasure — and hope of cracking a deadly flu’s secret

By Helen Branswell

He Jiankui slide presentation
In the Lab

The ‘CRISPR babies’ experiment was more flawed than scientists first realized

By Sharon Begley

Transplante útero
In the Lab

For the first time, a baby is born via a uterus transplant from a deceased donor

By Andrew Joseph

Charles Grassley
Politics

With new drug pricing legislation, Grassley and Wyden hint at the next steps for a powerful Senate committee

By Ike Swetlitz

NHS
Pharmalot

Will Vertex finally reach a deal with the U.K. over its cystic fibrosis drug?

By Ed Silverman

Biotech

Four big questions ahead of Moderna’s public debut — biotech’s biggest ever

By Damian Garde

Foundation Medicine
Biotech

For one cancer patient, biotech’s genetic test turns out to be a ‘lifesaver’

By Jonathan Saltzman — Boston Globe

Pharmalot

Pharmalittle: Insys pivots from opioids to cannabis-derived drugs; Republicans oppose Trump Medicare price plan

By Ed Silverman

Health workers - Ebola - DRC
First Opinion

It isn’t crazy to conduct an Ebola clinical trial in a war zone — it’s necessary

By Jeremy Farrar

The READOUT
The Readout

Tesaro’s silver lining & Novartis’ big pricing reveal

By Damian Garde

Centers for Disease Control
Morning Rounds

Cases of polio-like illness seem to peak & telemedicine trends

By Megan Thielking

Blurry doctors
First Opinion

Anomalies shed light on doctors’ compensation

By Halee Fischer-Wright and Todd Evenson

Pills price rebate
First Opinion

Drug ‘rebate walls’ should be dismantled by the FTC’s antitrust arm

By David Balto

Azar and Trump
Politics

The Trump administration has a new idea for changing drug rebates. That doesn’t mean it’s abandoning its earlier proposals

By Ike Swetlitz

China Gene Edited Babies
Exclusive

‘CRISPR babies’ lab asked U.S. scientist for help to disable cholesterol gene in human embryos

By Sharon Begley

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy